Covered recipient · General Payments record
MICHAEL E COLLIER
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,053.06
- Reported across 93 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $280.94 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $107.26 | 5 |
| ABBVIE INC. | $102.85 | 6 |
| Amgen Inc. | $38.62 | 2 |
| Esperion Therapeutics, Inc. | $18.07 | 1 |
| Acerta Pharma LLC | $14.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.80 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491301 | CMS |
| ABBVIE INC. | $15.53 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491303 | CMS |
| ABBVIE INC. | $20.15 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491305 | CMS |
| ABBVIE INC. | $13.37 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491307 | CMS |
| ABBVIE INC. | $15.20 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491309 | CMS |
| ABBVIE INC. | $18.80 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491311 | CMS |
| Amgen Inc. | $14.49 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117227192 | CMS |
| Amgen Inc. | $24.13 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115522735 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.14 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105574820 | CMS |
| Esperion Therapeutics, Inc. | $18.07 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129431524 | CMS |
| GlaxoSmithKline, LLC. | $24.74 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116529084 | CMS |
| GlaxoSmithKline, LLC. | $23.36 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116627234 | CMS |
| GlaxoSmithKline, LLC. | $20.69 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116642472 | CMS |
| GlaxoSmithKline, LLC. | $21.98 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116368732 | CMS |
| GlaxoSmithKline, LLC. | $16.49 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115916765 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.